Innate immune signaling drives late cardiac toxicity following DNA damaging cancer therapies
A. Shamseddine, S. Patel, V. Chavez, M. Adnan, M. Di Bona, J. Li, C. T. Dang, L. V. Ramanathan, K. C. Oeffinger, J. E. Liu, R. M. Steingart, A. Piersigilli, N. D. Socci, A. T. Chan, A. F. Yu, , A. M. Schmitt
This study identifies cGAS-STING signaling as a driver of late cardiac toxicity after DNA-damaging cancer therapies and shows that targeting this pathway can mitigate cardiotoxicity.
Journal of Experimental Medicine · Dec 19, 2022Peer-reviewedImmunology